Drahomir Aujesky

Summary

Country: Switzerland

Publications

  1. ncbi Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA
    Thromb Haemost 93:592-9. 2005
  2. ncbi Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Clin Epidemiol 58:357-63. 2005
  3. ncbi A prediction rule to identify low-risk patients with pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Arch Intern Med 166:169-75. 2006
  4. ncbi Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, PA, USA
    Chest 128:1601-10. 2005
  5. ncbi Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Med 118:384-92. 2005
  6. ncbi Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA
    Am J Med 118:625-35. 2005
  7. doi Thrombolytic therapy and mortality in patients with acute pulmonary embolism
    Said A Ibrahim
    Center for Health Equity Research and Promotion, Department of Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA 15206, USA
    Arch Intern Med 168:2183-90. 2008
  8. ncbi Gender differences in 30-day mortality for patients hospitalized with acute pulmonary embolism
    Sonya Borrero
    University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA
    J Womens Health (Larchmt) 16:1165-70. 2007
  9. pmc Racial differences in 30-day mortality for pulmonary embolism
    Said A Ibrahim
    Veterans Administration Center for Health Equity Research and Promotion, Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA
    Am J Public Health 96:2161-4. 2006
  10. doi Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Thromb Res 131:502-7. 2013

Research Grants

Detail Information

Publications31

  1. ncbi Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA
    Thromb Haemost 93:592-9. 2005
    ..However, because of the substantial pharmacy costs of extended low-molecular-weight heparin prophylaxis in the US, this treatment is relatively expensive compared with warfarin...
  2. ncbi Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Clin Epidemiol 58:357-63. 2005
    ..To assess the agreement between prospectively and retrospectively determined variables comprising the Pneumonia Severity Index (PSI), assignment to PSI risk class, and designation as low risk, based on these two methods of data collection...
  3. ncbi A prediction rule to identify low-risk patients with pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Arch Intern Med 166:169-75. 2006
    ..A simple prognostic model could help identify patients with pulmonary embolism who are at low risk of death and are candidates for outpatient treatment...
  4. ncbi Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, PA, USA
    Chest 128:1601-10. 2005
    ..Low-molecular-weight heparin (LMWH) appears to be safe and effective for treating pulmonary embolism (PE), but its cost-effectiveness has not been assessed...
  5. ncbi Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Med 118:384-92. 2005
    ....
  6. ncbi Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA
    Am J Med 118:625-35. 2005
    ..We used decision analysis to evaluate clinical and economic outcomes of different anticoagulation strategies with warfarin...
  7. doi Thrombolytic therapy and mortality in patients with acute pulmonary embolism
    Said A Ibrahim
    Center for Health Equity Research and Promotion, Department of Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA 15206, USA
    Arch Intern Med 168:2183-90. 2008
    ..In the management of acute pulmonary embolism, the prevalence of thrombolytic therapy is uncertain, and its benefits compared with standard anticoagulation remain a subject of debate...
  8. ncbi Gender differences in 30-day mortality for patients hospitalized with acute pulmonary embolism
    Sonya Borrero
    University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA
    J Womens Health (Larchmt) 16:1165-70. 2007
    ..We compared 30-day mortality for men and women hospitalized with PE using a large statewide database...
  9. pmc Racial differences in 30-day mortality for pulmonary embolism
    Said A Ibrahim
    Veterans Administration Center for Health Equity Research and Promotion, Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA
    Am J Public Health 96:2161-4. 2006
    ..We used a large statewide database to compare 30-day mortality (defined as death within 30 days from the date of latest hospital admission) for Black and White patients who were hospitalized because of pulmonary embolism...
  10. doi Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Thromb Res 131:502-7. 2013
    ..We aimed to prospectively evaluate whether unselected medical patients on oral anticoagulation have an increased risk of bleeding when on concomitant antiplatelet therapy...
  11. doi Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:1095-102. 2012
    ..We aimed to externally validate and compare the prognostic performance of 7 clinical prediction scores for major bleeding events during oral anticoagulation therapy...
  12. doi Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Lausanne, Lausanne, Switzerland
    Clin Infect Dis 49:e100-8. 2009
    ..We identified the reasons why ED providers hospitalize low-risk patients or manage higher-risk patients as outpatients...
  13. doi Risk of falls and major bleeds in patients on oral anticoagulation therapy
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:773-8. 2012
    ..We aimed to evaluate whether patients on oral anticoagulation with high falls risk have an increased risk of major bleeding...
  14. doi Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial
    Marc Righini
    Division of Angiology and Hemostasis, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland
    Lancet 371:1343-52. 2008
    ..We compared this combination with a strategy in which both a negative venous ultrasonography of the leg and MSCT were needed to exclude pulmonary embolism...
  15. ncbi African American race was associated with an increased risk of complications following venous thromboembolism
    Drahomir Aujesky
    Division of Internal Medicine, the Clinical Epidemiology Center, University of Lausanne, Lausanne, Switzerland
    J Clin Epidemiol 60:410-6. 2007
    ..Limited data exist on the quality of care for patients with venous thromboembolism (VTE), and it is unknown whether the processes and outcomes of care for this illness differ between African Americans and whites...
  16. ncbi Prognostic value of D-dimer in patients with pulmonary embolism
    Drahomir Aujesky
    Division of Internal Medicine, University of Lausanne, Lausanne, Switzerland
    Thromb Haemost 96:478-82. 2006
    ....
  17. ncbi Prediction of pulmonary embolism in the emergency department: the revised Geneva score
    Gregoire Le Gal
    Brest University Hospital, Brest, France
    Ann Intern Med 144:165-71. 2006
    ..Diagnosis of pulmonary embolism requires clinical probability assessment. Implicit assessment is accurate but is not standardized, and current prediction rules have shortcomings...
  18. ncbi Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism
    Isabelle Chagnon
    Division of Angiology and Hemostasis, Geneva University Hospital, Geneva, Switzerland
    Am J Med 113:269-75. 2002
    ..We compared the predictive accuracy and the concordance of the two methods, as well as the Geneva score overridden by implicit clinical judgment...
  19. ncbi Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism
    Gregoire Le Gal
    Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
    Arch Intern Med 166:176-80. 2006
    ....
  20. pmc Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement
    Drahomir Aujesky
    Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    J Gen Intern Med 17:788-91. 2002
    ..Quality of care interventions, such as the development of local guidelines, might improve the appropriateness of pharmacological thromboembolic prophylaxis in medical inpatients...
  21. pmc Derivation and validation of a prognostic model for pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, Clinical Epidemiology Center, University of Lausanne, Lausanne, Switzerland
    Am J Respir Crit Care Med 172:1041-6. 2005
    ..An objective and simple prognostic model for patients with pulmonary embolism could be helpful in guiding initial intensity of treatment...
  22. ncbi Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study
    Arnaud Perrier
    Medical Clinic 1, Geneva University Hospital, Switzerland
    Am J Med 116:291-9. 2004
    ..To evaluate a diagnostic strategy for pulmonary embolism that combined clinical assessment, plasma D-dimer measurement, lower limb venous ultrasonography, and helical computed tomography (CT)...
  23. ncbi Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome
    Mathieu R Nendaz
    Medical Clinic 1, Department of Internal Medicine, Geneva University Hospitals, Switzerland
    Thromb Haemost 91:1232-6. 2004
    ..Whether this score remains accurate and useful in clinical practice should be determined in a prospective multicentre validation study...
  24. ncbi Exclusion of pulmonary embolism using C-reactive protein and D-dimer. A prospective comparison
    Drahomir Aujesky
    Department of Medicine, University Hospital of Lausanne, Switzerland
    Thromb Haemost 90:1198-203. 2003
    ..Standard CRP tests alone or combined with clinical probability assessment cannot safely exclude PE...
  25. ncbi Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism
    Marc Righini
    Division of Angiology and Hemostasis, Geneva University Hospital, 24, Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Arch Intern Med 164:2483-7. 2004
    ....
  26. doi Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective
    Drahomir Aujesky
    Division of Internal Medicine, University of Lausanne, Service de Medecine Interne, BH 10 622, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
    Arch Intern Med 168:706-12. 2008
    ..Although reducing LOS is likely to save costs, the effects on patient safety are unclear. We sought to identify patient and hospital factors associated with LOS and assess whether LOS was associated with postdischarge mortality...
  27. pmc Hospital volume and patient outcomes in pulmonary embolism
    Drahomir Aujesky
    Division of Internal Medicine, University of Lausanne, Lausanne, Switzerland
    CMAJ 178:27-33. 2008
    ..For patients with pulmonary embolism, the relation between the number of patients treated in a hospital (volume) and patient outcome is unknown...
  28. ncbi [Oral anticoagulation and the risk of major bleeding]
    Monica Cosma Rochat
    Service de médecine interne BH10 622, CHUV, 1011 Lausanne
    Rev Med Suisse 3:2461-2, 2464-5. 2007
    ..The role of clinical prediction rules for major bleeding is discussed...
  29. ncbi Does guideline adherence for empiric antibiotic therapy reduce mortality in community-acquired pneumonia?
    Drahomir Aujesky
    Am J Respir Crit Care Med 172:655-6. 2005
  30. ncbi Validation of a model to predict adverse outcomes in patients with pulmonary embolism
    Drahomir Aujesky
    Division of General Internal Medicine, The University Outpatient Clinic and The Clinical Epidemiology Center, University of Lausanne, Lausanne, Switzerland
    Eur Heart J 27:476-81. 2006
    ..To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). The model was previously derived from 10 534 US patients...
  31. ncbi Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism
    Marc Righini
    Division of Angiology and Hemostasis, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Thromb Haemost 95:715-9. 2006
    ..Increasing the cut-off value of D-dimer in cancer patients might increase the test's clinical usefulness...

Research Grants1

  1. Identifying Low-Risk Patients with Pulmonary Embolism
    Drahomir Aujesky; Fiscal Year: 2005
    ..abstract_text> ..